Assiut University
Asyut, 71111111, Egypt
NCT Number: NCT04966208
Coronally the advanced flap is considered a predictable treatment of gingival recession but in certain situations, it needs a filler like subperiosteal connective tissue graft (CTG) which is considered as the gold standard treatment approach.
This randomized controlled trial compares the clinical benefits and effectiveness of a xenogenic collagen matrix (mucoderm, botiss, dental, Berlin, Germany) as a filler to the subperiosteal connective tissue graft (CTG).
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Asyut, 71111111, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
xenogeneic collagen matrix called mucoderm used for root coverage for treatment of gingival recession instead of harvesting from the patients connective tissue
Time frame: 6 months after the surgery
The distance from the tip of the papilla to the mucogingival junction minus the probing depth measured in mm using graduated periodontal probe.
Time frame: 6 months after the surgery
measured from the gingival margin to the depth of the gingival sulcus in six sites per tooth and measured in mm.
Time frame: 6 months after the surgery
measured from the cementoenamel junction to the depth of the sulcus in six sites per tooth and measured in mm.
Time frame: 6 months after the surgery
The depth measured from the gingival margin to the cementoenamel junction in mm.
Time frame: 6 months
measured using the visual analog scale.
Assiut University
Other
Root Coverage Using Tunneling Technique of Xenogenic Collagen Matrix vs. Autologous Connective Tissue as a Treatment of Miller Class Two Gingival Recession (RCT Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736833
Gingival Diseases, Gingival Recession
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT05470660
Gingival Diseases, Gingival Recession
Cairo, Egypt
View Trial DetailsNCT07291583
Gingival Diseases, Gingival Recession
Ankara, None Selected, Turkey (Türkiye)
View Trial DetailsNCT07616960
Gingival Diseases, Gingival Recession
Taipei, Taiwan
View Trial Details